Annual Operating Profit
-$14.64 M
+$12.44 M+45.94%
December 31, 2023
Summary
- As of February 7, 2025, RSLS annual operating income is -$14.64 million, with the most recent change of +$12.44 million (+45.94%) on December 31, 2023.
- During the last 3 years, RSLS annual operating profit has fallen by -$2.18 million (-17.52%).
- RSLS annual operating profit is now -31.26% below its all-time high of -$11.15 million, reached on December 31, 2005.
Performance
RSLS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$1.76 M
+$293.00 K+14.26%
September 30, 2024
Summary
- As of February 7, 2025, RSLS quarterly operating income is -$1.76 million, with the most recent change of +$293.00 thousand (+14.26%) on September 30, 2024.
- Over the past year, RSLS quarterly operating profit has increased by +$1.34 million (+43.25%).
- RSLS quarterly operating profit is now at all-time high.
Performance
RSLS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$7.92 M
+$1.34 M+14.49%
September 30, 2024
Summary
- As of February 7, 2025, RSLS TTM operating income is -$7.92 million, with the most recent change of +$1.34 million (+14.49%) on September 30, 2024.
- Over the past year, RSLS TTM operating profit has increased by +$10.05 million (+55.94%).
- RSLS TTM operating profit is now -22.75% below its all-time high of -$6.45 million, reached on September 30, 2007.
Performance
RSLS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
RSLS Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.9% | +43.3% | +55.9% |
| 3 y3 years | -17.5% | +88.3% | +67.2% |
| 5 y5 years | +40.4% | +18.9% | +33.3% |
RSLS Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +46.3% | at high | +80.1% | at high | +79.3% |
| 5 y | 5-year | -17.5% | +46.3% | at high | +88.3% | at high | +79.3% |
| alltime | all time | -31.3% | +59.6% | at high | +88.3% | -22.8% | +79.4% |
ReShape Lifesciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.76 M(-14.3%) | -$7.92 M(-14.5%) |
| Jun 2024 | - | -$2.05 M(-7.1%) | -$9.26 M(-17.4%) |
| Mar 2024 | - | -$2.21 M(+16.6%) | -$11.22 M(-23.4%) |
| Dec 2023 | -$14.64 M(-45.9%) | -$1.90 M(-38.9%) | -$14.64 M(-18.6%) |
| Sep 2023 | - | -$3.10 M(-22.6%) | -$17.98 M(-9.0%) |
| Jun 2023 | - | -$4.01 M(-28.8%) | -$19.74 M(-19.7%) |
| Mar 2023 | - | -$5.63 M(+7.6%) | -$24.60 M(-9.2%) |
| Dec 2022 | -$27.08 M(-0.6%) | -$5.23 M(+7.4%) | -$27.08 M(-3.8%) |
| Sep 2022 | - | -$4.87 M(-45.0%) | -$28.14 M(-26.4%) |
| Jun 2022 | - | -$8.86 M(+9.2%) | -$38.25 M(+15.6%) |
| Mar 2022 | - | -$8.11 M(+29.0%) | -$33.09 M(+21.5%) |
| Dec 2021 | -$27.23 M(+118.6%) | -$6.29 M(-58.0%) | -$27.23 M(+12.8%) |
| Sep 2021 | - | -$14.98 M(+304.8%) | -$24.15 M(+113.0%) |
| Jun 2021 | - | -$3.70 M(+64.0%) | -$11.34 M(+6.6%) |
| Mar 2021 | - | -$2.26 M(-29.6%) | -$10.63 M(-14.6%) |
| Dec 2020 | -$12.46 M(-21.6%) | -$3.20 M(+47.5%) | -$12.46 M(+4.8%) |
| Sep 2020 | - | -$2.17 M(-27.6%) | -$11.88 M(-14.1%) |
| Jun 2020 | - | -$3.00 M(-26.5%) | -$13.82 M(-12.1%) |
| Mar 2020 | - | -$4.08 M(+55.3%) | -$15.72 M(-1.0%) |
| Dec 2019 | -$15.89 M(-35.3%) | -$2.63 M(-36.2%) | -$15.89 M(-8.6%) |
| Sep 2019 | - | -$4.12 M(-15.9%) | -$17.38 M(-6.3%) |
| Jun 2019 | - | -$4.89 M(+15.3%) | -$18.55 M(-7.4%) |
| Mar 2019 | - | -$4.25 M(+3.2%) | -$20.03 M(-18.4%) |
| Dec 2018 | -$24.54 M(-12.5%) | -$4.12 M(-22.3%) | -$24.54 M(-15.4%) |
| Sep 2018 | - | -$5.29 M(-16.9%) | -$29.00 M(-0.9%) |
| Jun 2018 | - | -$6.37 M(-27.2%) | -$29.27 M(-1.7%) |
| Mar 2018 | - | -$8.76 M(+2.1%) | -$29.77 M(+6.1%) |
| Dec 2017 | -$28.05 M(+23.1%) | -$8.58 M(+54.3%) | -$28.05 M(+18.8%) |
| Sep 2017 | - | -$5.56 M(-19.1%) | -$23.61 M(+4.9%) |
| Jun 2017 | - | -$6.87 M(-2.4%) | -$22.51 M(+1.0%) |
| Mar 2017 | - | -$7.04 M(+70.5%) | -$22.30 M(-2.2%) |
| Dec 2016 | -$22.80 M(-18.2%) | -$4.13 M(-7.5%) | -$22.80 M(-13.0%) |
| Sep 2016 | - | -$4.46 M(-32.9%) | -$26.22 M(-5.6%) |
| Jun 2016 | - | -$6.66 M(-11.7%) | -$27.76 M(-2.4%) |
| Mar 2016 | - | -$7.54 M(-0.1%) | -$28.44 M(+2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | -$27.87 M(+8.9%) | -$7.55 M(+25.6%) | -$27.87 M(+5.5%) |
| Sep 2015 | - | -$6.01 M(-18.1%) | -$26.40 M(+1.6%) |
| Jun 2015 | - | -$7.34 M(+5.4%) | -$25.99 M(-0.1%) |
| Mar 2015 | - | -$6.96 M(+14.4%) | -$26.00 M(+1.6%) |
| Dec 2014 | -$25.59 M(+3.5%) | -$6.09 M(+8.8%) | -$25.59 M(-1.1%) |
| Sep 2014 | - | -$5.59 M(-23.9%) | -$25.88 M(-1.4%) |
| Jun 2014 | - | -$7.35 M(+12.1%) | -$26.26 M(+5.1%) |
| Mar 2014 | - | -$6.56 M(+2.9%) | -$24.97 M(+1.0%) |
| Dec 2013 | -$24.73 M(+9.7%) | -$6.37 M(+6.8%) | -$24.73 M(-1.5%) |
| Sep 2013 | - | -$5.97 M(-1.7%) | -$25.12 M(+1.6%) |
| Jun 2013 | - | -$6.07 M(-3.9%) | -$24.72 M(+5.7%) |
| Mar 2013 | - | -$6.32 M(-6.5%) | -$23.38 M(+3.7%) |
| Dec 2012 | -$22.55 M(-10.7%) | -$6.76 M(+21.3%) | -$22.55 M(-4.8%) |
| Sep 2012 | - | -$5.57 M(+17.8%) | -$23.67 M(-6.2%) |
| Jun 2012 | - | -$4.73 M(-13.8%) | -$25.24 M(-2.5%) |
| Mar 2012 | - | -$5.49 M(-30.4%) | -$25.89 M(+2.5%) |
| Dec 2011 | -$25.26 M(+56.1%) | -$7.89 M(+10.5%) | -$25.26 M(+20.3%) |
| Sep 2011 | - | -$7.13 M(+32.6%) | -$20.99 M(+16.9%) |
| Jun 2011 | - | -$5.38 M(+10.8%) | -$17.95 M(+7.6%) |
| Mar 2011 | - | -$4.86 M(+34.2%) | -$16.69 M(+3.1%) |
| Dec 2010 | -$16.18 M(-33.2%) | -$3.62 M(-11.6%) | -$16.18 M(-7.9%) |
| Sep 2010 | - | -$4.09 M(-0.5%) | -$17.57 M(-15.3%) |
| Jun 2010 | - | -$4.11 M(-5.4%) | -$20.74 M(-9.3%) |
| Mar 2010 | - | -$4.35 M(-13.3%) | -$22.86 M(-5.6%) |
| Dec 2009 | -$24.21 M(-33.2%) | -$5.02 M(-31.0%) | -$24.21 M(-5.7%) |
| Sep 2009 | - | -$7.27 M(+16.5%) | -$25.66 M(-9.8%) |
| Jun 2009 | - | -$6.23 M(+9.4%) | -$28.46 M(-14.9%) |
| Mar 2009 | - | -$5.70 M(-11.9%) | -$33.45 M(-7.8%) |
| Dec 2008 | -$36.27 M(+29.4%) | -$6.47 M(-35.7%) | -$36.27 M(-5.7%) |
| Sep 2008 | - | -$10.06 M(-10.4%) | -$38.47 M(+10.4%) |
| Jun 2008 | - | -$11.23 M(+31.8%) | -$34.86 M(+47.5%) |
| Mar 2008 | - | -$8.52 M(-1.8%) | -$23.64 M(+56.3%) |
| Dec 2007 | -$28.03 M(+54.7%) | -$8.67 M(+34.4%) | -$15.12 M(+134.4%) |
| Sep 2007 | - | -$6.45 M | -$6.45 M |
| Dec 2006 | -$18.12 M(+62.5%) | - | - |
| Dec 2005 | -$11.15 M | - | - |
FAQ
- What is ReShape Lifesciences annual operating income?
- What is the all time high annual operating profit for ReShape Lifesciences?
- What is ReShape Lifesciences annual operating profit year-on-year change?
- What is ReShape Lifesciences quarterly operating income?
- What is the all time high quarterly operating profit for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly operating profit year-on-year change?
- What is ReShape Lifesciences TTM operating income?
- What is the all time high TTM operating profit for ReShape Lifesciences?
- What is ReShape Lifesciences TTM operating profit year-on-year change?
What is ReShape Lifesciences annual operating income?
The current annual operating profit of RSLS is -$14.64 M
What is the all time high annual operating profit for ReShape Lifesciences?
ReShape Lifesciences all-time high annual operating income is -$11.15 M
What is ReShape Lifesciences annual operating profit year-on-year change?
Over the past year, RSLS annual operating income has changed by +$12.44 M (+45.94%)
What is ReShape Lifesciences quarterly operating income?
The current quarterly operating profit of RSLS is -$1.76 M
What is the all time high quarterly operating profit for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly operating income is -$1.76 M
What is ReShape Lifesciences quarterly operating profit year-on-year change?
Over the past year, RSLS quarterly operating income has changed by +$1.34 M (+43.25%)
What is ReShape Lifesciences TTM operating income?
The current TTM operating profit of RSLS is -$7.92 M
What is the all time high TTM operating profit for ReShape Lifesciences?
ReShape Lifesciences all-time high TTM operating income is -$6.45 M
What is ReShape Lifesciences TTM operating profit year-on-year change?
Over the past year, RSLS TTM operating income has changed by +$10.05 M (+55.94%)